LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, a global leader in early clinical research, proudly announces a new agreement to relocate its U.K. Phase 1 clinical research operations to iREACH Health. This ...
MIAMI, April 22, 2026 /PRNewswire/ -- H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $74 billion of capital under management, is pleased to announce that one of its ...
HIG Capital has agreed to sell Celerion Holdings, Inc, a Lincoln, Nebraska-based clinical research organization, to THL Partners. No financial terms were disclosed. Celerion’s services include data ...
LINCOLN, Neb--(BUSINESS WIRE)--Celerion, a leading clinical research organization, proudly announces its recent achievement of obtaining the Clinical Laboratory Improvement Amendments (CLIA) ...
Celerion announces the appointment of Dr. Bruce Morimoto as Executive Director of Applied Translational Medicine. Dr. Morimoto will also assume leadership for the External Studies Management and ...
Celerion Expands Belfast Facility with Containment Room to Enable Live Biologics and Vaccine Studies
(Lincoln, NE; June 5, 2013) – Celerion, announces the addition of a Containment Room at the Belfast, Northern Ireland, UK facility. The new Containment Room will allow Celerion to develop programs ...
Celerion, a global leader in early clinical research and bioanalytical services, today announced the expansion of its bioanalytical laboratory in Zurich, Switzerland. The investment strengthens ...
Celerion has expanded its laboratory capabilities in response to increasing demand for cell-based assays. Celerion has expanded its laboratory capabilities in response to increasing demand for ...
The company has designed a bioanalytical offering that supports drug development, from in-vitro metabolite identification to human ADME profiling studies. Celerion, a clinical research services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results